This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osman, M.
Right arrow Articles by Gotch, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osman, M.
Right arrow Articles by Gotch, F.

 Previous Article  |  Next Article 

Journal of Virology, July 1999, p. 6136-6140, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Identification of Human Herpesvirus 8-Specific Cytotoxic T-Cell Responses

Mohamed Osman,1,2 Toru Kubo,2 Jasjit Gill,3 Frank Neipel,4 Marion Becker,5 Geoffrey Smith,5 Robin Weiss,1 Brian Gazzard,3 Chris Boshoff,1,* and Frances Gotch2,*

Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg, D-91054 Erlangen, Germany,4 and Department of Genitourinary Medicine3 and Department of Immunology,2 Chelsea and Westminster Hospital, Imperial College School of Medicine, and Departments of Oncology and Molecular Pathology, Royal Free and University College Medical School, University College London,1 London, and Dunn School of Pathology, University of Oxford, Oxford,5 United Kingdom

Received 28 January 1999/Accepted 26 March 1999

Human herpesvirus 8 (HHV-8) (or Kaposi's sarcoma-associated herpesvirus) is implicated in the etiopathogenesis of Kaposi's sarcoma (KS) and certain lymphoproliferations. The introduction of more effective therapies to treat human immunodeficiency virus infection has led to a decline in the incidence of KS and also in the resolution of KS in those already affected. This suggests that cellular immune responses including cytotoxic T lymphocytes (CTLs) could play a vital role in the control of HHV-8 infection and in KS pathogenesis. Here we elucidate HLA class I-restricted, HHV-8-specific cellular immune responses that could be important in the control of HHV-8 infection and subsequent tumor development. We show the presence of CTLs against HHV-8 latent (K12), lytic (K8.1), and highly variable (K1) proteins in infected individuals.

* Corresponding author. Mailing address for Chris Boshoff: Department of Oncology, 91 Riding House St., University College London, London W1P 6BT, United Kingdom. Phone: 44-171-504-9557. Fax: 44-171-504-9555. E-mail: c.boshoff{at}ucl.ac.uk. Mailing address for Frances Gotch: Department of Immunology, Chelsea and Westminster Hospital, London SW10 9NH, United Kingdom. Phone: 44-181-746-8257. Fax: 44-181-746-5997. E-mail: f.gotch{at}ic.ac.uk.

Journal of Virology, July 1999, p. 6136-6140, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Guihot, A., Oksenhendler, E., Galicier, L., Marcelin, A.-G., Papagno, L., Bedin, A.-S., Agbalika, F., Dupin, N., Cadranel, J., Autran, B., Carcelain, G. (2008). Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells. Blood 111: 1387-1395 [Abstract] [Full Text]  
  • Sin, S.-H., Roy, D., Wang, L., Staudt, M. R., Fakhari, F. D., Patel, D. D., Henry, D., Harrington, W. J. Jr, Damania, B. A., Dittmer, D. P. (2007). Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 109: 2165-2173 [Abstract] [Full Text]  
  • Lambert, M., Gannage, M., Karras, A., Abel, M., Legendre, C., Kerob, D., Agbalika, F., Girard, P.-M., Lebbe, C., Caillat-Zucman, S. (2006). Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 108: 3871-3880 [Abstract] [Full Text]  
  • Bower, M., Mazhar, D., Stebbing, J. (2006). Should Cervical Cancer Be an Acquired Immunodeficiency Syndrome-Defining Cancer?. JCO 24: 2417-2419 [Full Text]  
  • Ribechini, E., Fortini, C., Marastoni, M., Traniello, S., Spisani, S., Monini, P., Gavioli, R. (2006). Identification of CD8+ T Cell Epitopes within Lytic Antigens of Human Herpes Virus 8. J. Immunol. 176: 923-930 [Abstract] [Full Text]  
  • Boulanger, E., Gerard, L., Gabarre, J., Molina, J.-M., Rapp, C., Abino, J.-F., Cadranel, J., Chevret, S., Oksenhendler, E. (2005). Prognostic Factors and Outcome of Human Herpesvirus 8-Associated Primary Effusion Lymphoma in Patients With AIDS. JCO 23: 4372-4380 [Abstract] [Full Text]  
  • Stebbing, J., Wildfire, A., Portsmouth, S., Powles, T., Thirlwell, C., Hewitt, P., Nelson, M., Patterson, S., Mandalia, S., Gotch, F., Gazzard, B. G., Bower, M. (2003). Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Ann Oncol 14: 1660-1666 [Abstract] [Full Text]  
  • Stebbing, J., Bourboulia, D., Johnson, M., Henderson, S., Williams, I., Wilder, N., Tyrer, M., Youle, M., Imami, N., Kobu, T., Kuon, W., Sieper, J., Gotch, F., Boshoff, C. (2003). Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes. J. Virol. 77: 4306-4314 [Abstract] [Full Text]  
  • Wang, Q. J., Huang, X.-L., Rappocciolo, G., Jenkins, F. J., Hildebrand, W. H., Fan, Z., Thomas, E. K., Rinaldo, C. R. Jr (2002). Identification of an HLA A*0201-restricted CD8+ T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood 99: 3360-3366 [Abstract] [Full Text]  
  • Kim, I.-J., Flano, E., Woodland, D. L., Blackman, M. A. (2002). Antibody-Mediated Control of Persistent {gamma}-Herpesvirus Infection. J. Immunol. 168: 3958-3964 [Abstract] [Full Text]  
  • Wilkinson, J., Cope, A., Gill, J., Bourboulia, D., Hayes, P., Imami, N., Kubo, T., Marcelin, A., Calvez, V., Weiss, R., Gazzard, B., Boshoff, C., Gotch, F. (2002). Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy. J. Virol. 76: 2634-2640 [Abstract] [Full Text]  
  • Rimessi, P., Bonaccorsi, A., Sturzl, M., Fabris, M., Brocca-Cofano, E., Caputo, A., Melucci-Vigo, G., Falchi, M., Cafaro, A., Cassai, E., Ensoli, B., Monini, P. (2001). Transcription Pattern of Human Herpesvirus 8 Open Reading Frame K3 in Primary Effusion Lymphoma and Kaposi's Sarcoma. J. Virol. 75: 7161-7174 [Abstract] [Full Text]  
  • Wang, Q. J., Jenkins, F. J., Jacobson, L. P., Kingsley, L. A., Day, R. D., Zhang, Z.-W., Meng, Y.-X., Pellet, P. E., Kousoulas, K. G., Baghian, A., Rinaldo, C. R. Jr (2001). Primary human herpesvirus 8 infection generates a broadly specific CD8+ T-cell response to viral lytic cycle proteins. Blood 97: 2366-2373 [Abstract] [Full Text]  
  • Low, W., Harries, M., Ye, H., Du, M.-Q., Boshoff, C., Collins, M. (2001). Internal Ribosome Entry Site Regulates Translation of Kaposi's Sarcoma-Associated Herpesvirus FLICE Inhibitory Protein. J. Virol. 75: 2938-2945 [Abstract] [Full Text]  
  • Samaniego, F., Pati, S., Karp, J. E., Prakash, O., Bose, D. (2000). Human Herpesvirus 8 K1-Associated Nuclear Factor-kappa B-Dependent Promoter Activity: Role in Kaposi's Sarcoma Inflammation?. J Natl Cancer Inst Monogr 2000: 15-23 [Abstract] [Full Text]  
  • Usherwood, E. J., Roy, D. J., Ward, K., Surman, S. L., Dutia, B. M., Blackman, M. A., Stewart, J. P., Woodland, D. L. (2000). Control of Gammaherpesvirus Latency by Latent Antigen-Specific Cd8+ T Cells. JEM 192: 943-952 [Abstract] [Full Text]  
  • Brander, C., Suscovich, T., Lee, Y., Nguyen, P. T., O'Connor, P., Seebach, J., Jones, N. G., van Gorder, M., Walker, B. D., Scadden, D. T. (2000). Impaired CTL Recognition of Cells Latently Infected with Kaposi's Sarcoma-Associated Herpes Virus. J. Immunol. 165: 2077-2083 [Abstract] [Full Text]  
  • Antman, K., Chang, Y. (2000). Kaposi's Sarcoma. NEJM 342: 1027-1038 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»